KARA GUGLIELMO: Open Payments
NPI 1326817974 · AURORA, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$614 in 26 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $614
Food & beverage: $614
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $175 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| Alkermes, Inc. | 3 | $74 |
| Tris Pharma Inc | 2 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Bausch Health US, LLC | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
Products named: VRAYLAR, REXULTI, ARISTADA, Dyanavel XR, CAPLYTA, APLENZIN, FANAPT, Auvelity.
Industry payments across CO — which companies pay providers there.
